Literature DB >> 5290549

Comparison of the bronchodilator and cardiovascular actions of salbutamol, isoprenaline and orciprenaline in guinea-pigs and dogs.

M J Daly, J B Farmer, G P Levy.   

Abstract

1. Bronchodilator and cardiovascular actions of salbutamol and isoprenaline have been compared in guinea-pigs and dogs. Orciprenaline was also included in some experiments.2. All three drugs antagonized acetylcholine-induced increases in pulmonary resistance. In addition they increased heart rate and decreased arterial blood pressure.3. Compared with isoprenaline, salbutamol has relatively stronger actions on bronchial and vascular beta-adrenoceptors than on cardiac beta-adrenoceptors, on which its action is very weak. In contrast, orciprenaline has similar potencies on beta-adrenoceptors in these three tissues.4. The positive chronotropic potency of intravenously or orally administered salbutamol was increased in conscious dogs. These heart rate responses to salbutamol were probably mainly reflex in origin.5. Salbutamol and orciprenaline were both longer acting than isoprenaline.6. The results support the idea of two distinct groups of beta-adrenoceptors. Salbutamol differentiates between bronchial and vascular beta(2)-adrenoceptors on the one hand and cardiac beta(1)-adrenoceptors on the other. Isoprenaline and orciprenaline do not differentiate between beta(1)- and beta(2)-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5290549      PMCID: PMC1665801          DOI: 10.1111/j.1476-5381.1971.tb07192.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Mechanics of respiration in unanesthetized guinea pigs.

Authors:  M O AMDUR; J MEAD
Journal:  Am J Physiol       Date:  1958-02

2.  A comparison of the beta-adrenoreceptor stimulant properties of isoprenaline, with those of orciprenaline, salbutamol, soterenol and trimetoquinol on isolated atria and trachea of the guinea pig.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  J Pharm Pharmacol       Date:  1970-01       Impact factor: 3.765

3.  A selective beta-adrenoreceptor stimulant (Th1165a) related to orciprenaline.

Authors:  S R O'Donnell
Journal:  Eur J Pharmacol       Date:  1970-09-01       Impact factor: 4.432

4.  Beta-receptors in human isolated smooth muscle.

Authors:  A Hedges; P Turner
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

5.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

6.  Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity.

Authors:  A E Tattersfield; M W McNicol
Journal:  N Engl J Med       Date:  1969-12-11       Impact factor: 91.245

7.  Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator.

Authors:  M C Kennedy; W T Simpson
Journal:  Br J Dis Chest       Date:  1969-07

8.  Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man.

Authors:  L E Martin; J C Hobson; J A Page; C Harrison
Journal:  Eur J Pharmacol       Date:  1971-04       Impact factor: 4.432

9.  Absorption and elimination profile of isoproterenol. 3. The metabolic fate of dl-isoproterenol-7-3H in the dog.

Authors:  W D Conway; H Minatoya; A M Lands; J M Shekosky
Journal:  J Pharm Sci       Date:  1968-07       Impact factor: 3.534

10.  Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.

Authors:  V A Cullum; J B Farmer; D Jack; G P Levy
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739

View more
  24 in total

1.  Effects of adrenaline, noradrenaline, isoprenaline and salbutamol on the production and release of renin by isolated renal cortical cells of the cat.

Authors:  E J Johns; H K Richards; B Singer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

2.  Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients.

Authors:  A Salvetti; L Poli; F Arzilli; L Sassano; R Pedrinelli; M Motolese
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

3.  Influence of isoprenaline and salbutamol on the threshold of electrically induced ventricular fibrillation in anaesthetized guinea pigs.

Authors:  D Hellenbrecht; L Gortner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

4.  The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

5.  Lack of cardiac or bronchodilator tachyphylaxis to isoprenaline in the dog.

Authors:  H Minatoya; B A Spilker
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

6.  Beta adrenoceptors in the hepatic arterial vascular bed of the dog [proceedings].

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

7.  alpha And beta-adrenoceptors in the detrusor muscle and bladder base of the pig and beta-adrenoceptors in the detrusor muscle of man.

Authors:  J J Larsen
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

8.  The role of beta1- and beta2-adrenoceptors in the inhibition of gastric acid secretion in the dog.

Authors:  M J Daly; J M Long; R Stables
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

9.  Pulmonary mechanical effects of experimental lung embolism and their modification by bronchodilator drugs in the guinea-pig.

Authors:  M J Daly
Journal:  Br J Pharmacol       Date:  1974-08       Impact factor: 8.739

10.  Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs.

Authors:  N Taira; Y Yabuuchi; S Yamashita
Journal:  Br J Pharmacol       Date:  1977-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.